Discover

RZLT
Rezolute, Inc.
4.71
6 x 4.69
9 x 4.70
bid
ask
+
0.03
0.64%
12:37 PM
timesize
Ytd99.58%
1y-20.71%
4.63
day range
4.71
1.07
52 week range
11.46
Open4.65Prev Close4.68Low4.63High4.71Mkt Cap452.19M
Vol204.22KAvg Vol1.82MEPS-0.82P/E-5.73Forward P/E-3.42
Beta0.58Short Ratio3.16Inst. Own64.24%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-1250-d Avg4.67200-d Avg4.591yr Est13.00

RZLT News

Rezolute to Participate in the BTIG Virtual Biotechnology Conference
globenewswire.com
Rezolute to Participate in the BTIG Virtual Biotechnology Conference

REDWOOD CITY, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
globenewswire.com
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinic

Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis

RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?
zacks.com
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?

Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
globenewswire.com
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

REDWOOD CITY, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
benzinga.com
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stock

U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock

Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study
benzinga.com
Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study

Rezolute, Inc. (NASDAQ:RZLT) reported an interim update from its ongoing Phase 3 upLIFT study evalua

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
globenewswire.com
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperins

Study now 50% enrolled 6 of 8 participants have already met the responder criterion for the study's

Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
globenewswire.com
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute to Participate in Upcoming Investor Conferences
globenewswire.com
Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
globenewswire.com
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patie

Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrat

Rezolute, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
Rezolute, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rezolute, Inc., (“Rezol

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
globenewswire.com
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pedi

Oral presentation will include previously announced topline results as well as pre-specified and pos

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
zacks.com
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earli

FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question
benzinga.com
FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question

In a recent update, Rezolute shared insights from its March 17 meeting with the FDA regarding its Ph

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
globenewswire.com
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

REDWOOD CITY, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

Reviewing Rezolute (NASDAQ:RZLT) & ADMA Biologics (NASDAQ:ADMA)
defenseworld.net
Reviewing Rezolute (NASDAQ:RZLT) & ADMA Biologics (NASDAQ:ADMA)

ADMA Biologics (NASDAQ: ADMA - Get Free Report) and Rezolute (NASDAQ: RZLT - Get Free Report) are bo

RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute
businesswire.com
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute

NEW YORK--(BUSINESS WIRE)---- $RZLT #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT)
prnewswire.com
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (R

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suf

Rezolute to Participate in the Citizens Life Sciences Conference
globenewswire.com
Rezolute to Participate in the Citizens Life Sciences Conference

REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
globenewswire.com
RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolu

Faruqi & Faruqi, LLP Securities Litigation Partner  James (Josh) Wilson Encourages Investors Who Suf

RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
prnewswire.com
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suf

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Crude Oil Down 2%; Ciena Posts Upbeat Earnings
benzinga.com
Crude Oil Down 2%; Ciena Posts Upbeat Earnings

Dow Jumps Over 200 Points; Oracle Shares Plunge After Q2 Results
benzinga.com
Dow Jumps Over 200 Points; Oracle Shares Plunge After Q2 Results

Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Sess

benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 120 companies set new 52-week lows.

benzinga.com
88 Biggest Movers From Yesterday

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren rece

benzinga.com
Stocks That Hit 52-Week Highs On Monday

  This morning 180 companies set new 52-week highs.